Mission Wealth Management LP Has $5.08 Million Position in Stryker Corporation $SYK

Mission Wealth Management LP raised its stake in shares of Stryker Corporation (NYSE:SYK) by 12.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,836 shares of the medical technology company’s stock after buying an additional 1,459 shares during the period. Mission Wealth Management LP’s holdings in Stryker were worth $5,078,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. GHP Investment Advisors Inc. lifted its position in Stryker by 1.9% during the 2nd quarter. GHP Investment Advisors Inc. now owns 38,010 shares of the medical technology company’s stock worth $15,038,000 after acquiring an additional 724 shares during the last quarter. Plato Investment Management Ltd increased its stake in Stryker by 1.5% in the second quarter. Plato Investment Management Ltd now owns 11,600 shares of the medical technology company’s stock valued at $4,572,000 after acquiring an additional 166 shares during the period. Atlas Private Wealth Advisors increased its stake in Stryker by 5.8% in the second quarter. Atlas Private Wealth Advisors now owns 842 shares of the medical technology company’s stock valued at $333,000 after acquiring an additional 46 shares during the period. Gould Asset Management LLC CA grew its stake in Stryker by 7.4% during the second quarter. Gould Asset Management LLC CA now owns 1,603 shares of the medical technology company’s stock worth $634,000 after buying an additional 110 shares during the last quarter. Finally, Kesler Norman & Wride LLC grew its stake in Stryker by 101.2% during the second quarter. Kesler Norman & Wride LLC now owns 17,379 shares of the medical technology company’s stock worth $6,877,000 after buying an additional 8,741 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on SYK shares. UBS Group set a $408.00 price objective on shares of Stryker in a research note on Monday, October 13th. Redburn Partners set a $420.00 price objective on shares of Stryker in a report on Thursday, September 18th. Weiss Ratings restated a “buy (b-)” rating on shares of Stryker in a report on Wednesday, October 8th. Truist Financial dropped their price objective on shares of Stryker from $415.00 to $407.00 and set a “hold” rating on the stock in a report on Wednesday, October 15th. Finally, Wells Fargo & Company raised their price objective on shares of Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Thirteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Stryker presently has an average rating of “Moderate Buy” and an average target price of $434.16.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Viju Menon sold 500 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 5.90% of the stock is owned by insiders.

Stryker Stock Down 3.5%

Shares of SYK stock opened at $356.15 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The firm’s fifty day moving average price is $378.08 and its two-hundred day moving average price is $380.80. The firm has a market capitalization of $136.16 billion, a P/E ratio of 47.17, a PEG ratio of 2.66 and a beta of 0.94.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The firm had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. During the same period in the previous year, the business earned $2.87 EPS. The company’s revenue was up 10.2% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, equities analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th were paid a dividend of $0.84 per share. The ex-dividend date was Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s payout ratio is currently 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.